Physician

Andrea Gaito, MD

According to 2025 Medicare claims, Andrea Gaito, MD (NPI: 1487781787) practices rheumatology in the Newark, NJ market, with the plurality of this provider's patient population coming from Morris, NJ. Gaito uses personal NPI as billing NPI and primary practice location at 07920-1453.

Gaito's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 192 traditional Medicare patients, billed 787 HCPCS/CPT codes, and received $56,756 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 624 prescription claims across 140 beneficiaries totaling $515,990 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 30 records totaling $714. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $349,128 to $515,990. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$29K$58K2015 Medicare payment: $45,732 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $46,772 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $52,570 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $45,087 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $49,070 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $42,537 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $50,984 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $48,952 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $57,987 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $56,756 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015191746$45,732
2016201744$46,772
2017227876$52,570
2018192736$45,087
2019191724$49,070
2020165656$42,537
2021173726$50,984
2022167705$48,952
2023194798$57,987
2024192787$56,756

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$309K$617K2015 Drug cost: $349,128 (USD; Tot_Drug_Cst)2016 Drug cost: $313,421 (USD; Tot_Drug_Cst)2017 Drug cost: $347,882 (USD; Tot_Drug_Cst)2018 Drug cost: $349,483 (USD; Tot_Drug_Cst)2019 Drug cost: $352,121 (USD; Tot_Drug_Cst)2020 Drug cost: $365,383 (USD; Tot_Drug_Cst)2021 Drug cost: $607,325 (USD; Tot_Drug_Cst)2022 Drug cost: $617,446 (USD; Tot_Drug_Cst)2023 Drug cost: $498,836 (USD; Tot_Drug_Cst)2024 Drug cost: $515,990 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015101749$349,128
201693718$313,421
2017124712$347,882
2018112680$349,483
2019123701$352,121
2020119598$365,383
2021138616$607,325
2022118598$617,446
2023131606$498,836
2024140624$515,990

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more8181$165
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more115267$124
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2254$87
36410Insertion of needle into vein (3 years or older)180372$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept321,092$283,594
HumiraAdalimumab13364$88,194
Hydroxychloroquine SulfateHydroxychloroquine Sulfate736,310$5,354
CefuroximeCefuroxime Axetil451,314$1,835
CelecoxibCelecoxib161,340$1,038

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.30$714Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrea Gaito, MD?

Tedicare shows public-source Medicare data for Andrea Gaito, MD (NPI 1487781787), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrea Gaito, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrea Gaito, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Andrea Gaito, MD have Open Payments data?

Andrea Gaito, MD has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.